Selection of chemotherapy for metastatic mammary cancer by effect on cesium-131 uptake.
Cesium-131 was administered intravenously to 39 patients with superficial metastases of mammary carcinoma and the concentration in tumor was compared with that in normal tissue by application of a detector in vivo, before and after 1 to 5 days of chemotherapy with cyclophosphamide (CP), 5-fluorouracil (FU), or diethylstilbestrol. A change of the cesium concentration ratio (tumor/normal tissue) greater than 15% after brief treatment correctly predicted the therapeutic effect after 1 to 39 months on the tumors that were tested in 30 of 33 tests. No reliable correlation could be made in the remaining 21 tests in which the change of ratio was less than 15%. The concentration of cesium-131 in the skin, fat, and skeletal muscle of mice was not appreciably altered by treatment for 5 days with CP or FU.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D002586:Cesium / Q000378:metabolism*; D002588:Cesium Radioisotopes; D003520:Cyclophosphamide / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D009362:Neoplasm Metastasis; D011877:Radionuclide Imaging; D011960:Receptors, Estrogen / Q000032:analysis; D012008:Recurrence; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents; D002588:Cesium Radioisotopes; D011960:Receptors, Estrogen; D002586:Cesium; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; D005472:Fluorouracil